• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多项3D-QSAR建模、电子药效团、分子对接以及探索新型乙酰胆碱酯酶抑制剂的研究。

Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and study to explore novel AChE inhibitors.

作者信息

Jana Srabanti, Ganeshpurkar Ankit, Singh Sushil Kumar

机构信息

Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University) Varanasi-221005 India

出版信息

RSC Adv. 2018 Nov 26;8(69):39477-39495. doi: 10.1039/c8ra08198k. eCollection 2018 Nov 23.

DOI:10.1039/c8ra08198k
PMID:35558010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9091215/
Abstract

Ligand-based and energy-optimized structure-based approaches were considered to obtain excellent candidates as AChE inhibitors. The known AChE inhibitors were utilized to develop a pharmacophore hypothesis, HPRRR and X-ray crystallographic structures of AChE were used to produce three e-pharmacophore hypotheses . AHHRR, AHRR, and DHRR. Based on approaches, we came across eight structurally diverse hits as non-competitive AChE inhibitors with good ADME properties. The best four hits, ZINC20592007, ZINC05354646, ZINC20649934, and ZINC39154782 were non-toxic, neuroprotective, and were selective AChE inhibitors (IC values 482 ± 1.88 nM, 580 ± 1.63 nM, 854 ± 2.65 nM, and 636 ± 1.79 nM respectively). The hits showed non-competitive inhibition of AChE at PAS site with attractive values (0.21 ± 0.027 μM, 0.27 ± 0.064 μM, 0.3 ± 0.018 μM, and 0.28 ± 0.032 μM for ZINC20592007, ZINC05354646, ZINC20649934, and ZINC39154782 respectively), and increased the cholinergic activity as well as inhibited Aβ aggregation.

摘要

基于配体和能量优化的基于结构的方法被认为可获得作为乙酰胆碱酯酶(AChE)抑制剂的优秀候选物。利用已知的AChE抑制剂来建立药效团假设,AChE的HPRRR和X射线晶体学结构被用于生成三个电子药效团假设,即AHHRR、AHRR和DHRR。基于这些方法,我们发现了八种结构多样的命中物,它们作为具有良好药物代谢动力学(ADME)性质的非竞争性AChE抑制剂。最佳的四个命中物,即ZINC20592007、ZINC05354646、ZINC20649934和ZINC39154782是无毒的、具有神经保护作用的,并且是选择性AChE抑制剂(IC值分别为482±1.88 nM、580±1.63 nM、854±2.65 nM和636±1.79 nM)。这些命中物在PAS位点对AChE表现出非竞争性抑制,具有吸引人的解离常数(ZINC20592007、ZINC05354646、ZINC20649934和ZINC39154782分别为0.21±0.027 μM、0.27±0.064 μM、0.3±0.0

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ad1ece152b61/c8ra08198k-f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/3eb8d5d6bca2/c8ra08198k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/f027ceb6808b/c8ra08198k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/56985b414887/c8ra08198k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ec80ebd118d4/c8ra08198k-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/155129aa4253/c8ra08198k-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/17f8e8b621d8/c8ra08198k-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/3292347eed78/c8ra08198k-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/0d066ba41164/c8ra08198k-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ac66644222eb/c8ra08198k-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/c8a7868f2e77/c8ra08198k-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/31f390116a96/c8ra08198k-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/9488fe171b62/c8ra08198k-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ebff054ef587/c8ra08198k-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ad1ece152b61/c8ra08198k-f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/3eb8d5d6bca2/c8ra08198k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/f027ceb6808b/c8ra08198k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/56985b414887/c8ra08198k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ec80ebd118d4/c8ra08198k-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/155129aa4253/c8ra08198k-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/17f8e8b621d8/c8ra08198k-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/3292347eed78/c8ra08198k-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/0d066ba41164/c8ra08198k-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ac66644222eb/c8ra08198k-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/c8a7868f2e77/c8ra08198k-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/31f390116a96/c8ra08198k-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/9488fe171b62/c8ra08198k-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ebff054ef587/c8ra08198k-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/9091215/ad1ece152b61/c8ra08198k-f14.jpg

相似文献

1
Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and study to explore novel AChE inhibitors.多项3D-QSAR建模、电子药效团、分子对接以及探索新型乙酰胆碱酯酶抑制剂的研究。
RSC Adv. 2018 Nov 26;8(69):39477-39495. doi: 10.1039/c8ra08198k. eCollection 2018 Nov 23.
2
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.通过多电子药效团、基于配体的药效团、分子对接和密度泛函理论方法鉴定选择性 MMP-9 抑制剂。
J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9.
3
Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.基于场的3D-QSAR、基于药效团模型的虚拟筛选、分子对接、MM/GBSA、ADME和分子动力学模拟研究鉴定用于阿尔茨海默病的靶向乙酰胆碱酯酶的香豆素衍生物
Curr Res Struct Biol. 2024 Jan 7;7:100124. doi: 10.1016/j.crstbi.2024.100124. eCollection 2024.
4
Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.利用定量构效关系(QSAR)、药效团建模、分子对接和药物代谢及药物动力学(ADME)预测设计新型淀粉样β蛋白聚集抑制剂
In Silico Pharmacol. 2018 Jun 15;6(1):12. doi: 10.1007/s40203-018-0049-1. eCollection 2018.
5
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.发现新的苯磺酰基嘧啶羧酸衍生物作为具有有效抗阿尔茨海默病作用的潜在多靶标药物:设计、合成、晶体结构和体外生物学评价。
Eur J Med Chem. 2021 Apr 5;215:113224. doi: 10.1016/j.ejmech.2021.113224. Epub 2021 Feb 2.
6
Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors.基于药效团的虚拟筛选、3D QSAR、对接、ADMET 和 MD 模拟研究:从计算角度鉴定新的潜在 HDAC3 抑制剂。
Comput Biol Med. 2023 Nov;166:107481. doi: 10.1016/j.compbiomed.2023.107481. Epub 2023 Sep 16.
7
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.发现新型乙酰胆碱酯酶抑制剂作为治疗阿尔茨海默病的潜在候选药物。
Int J Mol Sci. 2019 Feb 25;20(4):1000. doi: 10.3390/ijms20041000.
8
Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.基于药效团映射的虚拟筛选,随后进行分子对接研究,以寻找潜在的乙酰胆碱酯酶抑制剂作为抗阿尔茨海默病药物。
Biosystems. 2014 Feb;116:10-20. doi: 10.1016/j.biosystems.2013.12.002. Epub 2013 Dec 8.
9
A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.基于药效团模型、QSAR 研究、分子对接和计算机 ADME/Tox 预测的 4-芳基硫代和 4-芳氧基-3-碘吡啶-2(1H)-酮类似物的综合方法,以鉴定潜在的逆转录酶抑制剂:抗 HIV 药物。
Med Chem. 2022;18(1):51-87. doi: 10.2174/1573406417666201214100822.
10
Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.结合指纹图谱、分子对接和基于结构的药效团方法开发乙酰胆碱酯酶抑制剂的3D-QSAR模型
Toxicol Sci. 2015 Nov;148(1):60-70. doi: 10.1093/toxsci/kfv160. Epub 2015 Jul 21.

引用本文的文献

1
Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations.通过虚拟筛选、对接和分子动力学模拟鉴定靶向脓肿分枝杆菌InhA的新型抑制剂。
Sci Rep. 2025 Apr 14;15(1):12795. doi: 10.1038/s41598-025-97513-2.
2
Identification of novel SARS-CoV-2 3CLpro inhibitors by molecular docking, assays, molecular dynamics simulations and DFT analyses.通过分子对接、实验、分子动力学模拟和密度泛函理论分析鉴定新型严重急性呼吸综合征冠状病毒2 3C样蛋白酶抑制剂
Front Pharmacol. 2024 Oct 30;15:1494953. doi: 10.3389/fphar.2024.1494953. eCollection 2024.
3
Investigating the electronic properties and reactivity of polyaniline emeraldine base functionalized with metal oxides.

本文引用的文献

1
New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase.具有胆碱能、抗氧化、调节β-淀粉样蛋白聚集和神经保护特性的新型黄酮-氰基乙酰胺杂合体,作为阿尔茨海默病的创新多功能治疗候选药物,并通过乙酰胆碱酯酶研究其作用机制。
Mol Pharm. 2018 Jun 4;15(6):2206-2223. doi: 10.1021/acs.molpharmaceut.8b00041. Epub 2018 May 24.
2
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.哌嗪二酮作为治疗阿尔茨海默病的双重抑制剂的研发
Eur J Med Chem. 2018 Apr 25;150:87-101. doi: 10.1016/j.ejmech.2018.02.078. Epub 2018 Feb 27.
3
研究金属氧化物功能化的聚苯胺翡翠碱的电子性质和反应活性。
Sci Rep. 2024 Nov 6;14(1):27024. doi: 10.1038/s41598-024-72435-7.
4
Glucosinolates and Indole-3-carbinol from L. as inhibitors of CdtB: insights from molecular docking, dynamics, DFT and in vitro assay.来自罗勒属植物的硫代葡萄糖苷和吲哚 - 3 - 甲醇作为CdtB抑制剂:分子对接、动力学、密度泛函理论及体外实验的见解
In Silico Pharmacol. 2024 Oct 29;12(2):95. doi: 10.1007/s40203-024-00276-3. eCollection 2024.
5
Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications.探索硫氧还蛋白系统作为癌症治疗靶点:机制与意义
Antioxidants (Basel). 2024 Sep 4;13(9):1078. doi: 10.3390/antiox13091078.
6
Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases.用于神经退行性疾病的新型 Tau 蛋白 - 微管蛋白激酶 1 抑制剂的计算设计
Pharmaceuticals (Basel). 2024 Jul 16;17(7):952. doi: 10.3390/ph17070952.
7
Investigation of Newly Synthesized Fluorinated Isatin-Hydrazones by Antiproliferative Activity, Molecular Docking, ADME Analysis, and e-Pharmacophore Modeling.通过抗增殖活性、分子对接、ADME分析和电子药效团建模对新合成的氟化异吲哚酮腙进行研究。
ACS Omega. 2024 Jun 5;9(24):26503-26518. doi: 10.1021/acsomega.4c03014. eCollection 2024 Jun 18.
8
Investigation of 3-Phenylcoumarin Derivatives as Potential Multi-target Inhibitors for Human Cholinesterases and Monoamine oxidases: A Computational Approach.3-苯基香豆素衍生物作为人胆碱酯酶和单胺氧化酶潜在多靶点抑制剂的研究:一种计算方法。
Appl Biochem Biotechnol. 2024 Nov;196(11):8389-8409. doi: 10.1007/s12010-024-04996-2. Epub 2024 Jun 14.
9
ADME profiling, molecular docking, DFT, and MEP analysis reveal cissamaline, cissamanine, and cissamdine from L.f. as potential anti-Alzheimer's agents.药代动力学特征分析、分子对接、密度泛函理论(DFT)和分子静电势(MEP)分析表明,来自锡生藤(L.f.)的锡生藤灵、锡生藤宁和锡生藤定是潜在的抗阿尔茨海默病药物。
RSC Adv. 2024 Mar 25;14(14):9878-9891. doi: 10.1039/d4ra01070a. eCollection 2024 Mar 20.
10
Effect of sulfonamide derivatives of on scopolamine-induced amnesia in rats.[具体名称]的磺胺衍生物对大鼠东莨菪碱诱导失忆的影响。 (注:原文中“of”后面缺少具体内容)
Ibrain. 2023 Feb 14;9(1):13-31. doi: 10.1002/ibra.12092. eCollection 2023 Spring.
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.通过多电子药效团、基于配体的药效团、分子对接和密度泛函理论方法鉴定选择性 MMP-9 抑制剂。
J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9.
4
FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery.FAF-Drugs4:用于化学生物学和早期药物发现的免费 ADME-tox 筛选计算。
Bioinformatics. 2017 Nov 15;33(22):3658-3660. doi: 10.1093/bioinformatics/btx491.
5
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.泛分析干扰化合物的出现频率有多高?大规模筛选数据的分析揭示了多样化的活性特征、低的全球命中频率以及许多始终不活跃的化合物。
J Med Chem. 2017 May 11;60(9):3879-3886. doi: 10.1021/acs.jmedchem.7b00154. Epub 2017 Apr 25.
6
Structure-based screening, ADMET profiling, and molecular dynamic studies on mGlu2 receptor for identification of newer antiepileptic agents.基于结构的筛选、ADMET 分析和分子动力学研究,鉴定新型抗癫痫药物的 mGlu2 受体。
J Biomol Struct Dyn. 2017 Dec;35(16):3433-3448. doi: 10.1080/07391102.2016.1257440. Epub 2016 Nov 28.
7
The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.通过药效团建模、虚拟筛选、对接模拟和生物测定发现新型乙酰胆碱酯酶抑制剂。
Mol Biosyst. 2016 Nov 15;12(12):3734-3742. doi: 10.1039/c6mb00661b.
8
KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries.用于评估SMARTS格式PAINS过滤器的KNIME工作流程。RDKit和Indigo化学信息学库的比较。
Mol Inform. 2011 Oct;30(10):847-50. doi: 10.1002/minf.201100076. Epub 2011 Aug 4.
9
ZINC 15--Ligand Discovery for Everyone.锌15——面向大众的配体发现平台。
J Chem Inf Model. 2015 Nov 23;55(11):2324-37. doi: 10.1021/acs.jcim.5b00559. Epub 2015 Nov 9.
10
In vitro evaluation and in silico screening of synthetic acetylcholinesterase inhibitors bearing functionalized piperidine pharmacophores.具有功能化哌啶药效基团的合成乙酰胆碱酯酶抑制剂的体外评价和计算机模拟筛选
Bioorg Med Chem. 2015 Aug 1;23(15):4567-4575. doi: 10.1016/j.bmc.2015.06.005. Epub 2015 Jun 9.